PRICE INQUIRY no. SEMA/2/68048/2023 - being conducted as a market assessment study

PRICE INQUIRY no. SEMA/2/68048/2023 - being conducted as a market assessment study

In connection with the implementation of the project titled “Design and development of an innovative solution - a generic drug from the group of GLP-1 receptor agonists in the treatment of type 2 diabetes”, funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a bid for the purchase and delivery of Semaglutide reference standard. Details of the price inquiry can be found in the documents attached below.

go back